Updated
Updated · erictopol.substack.com · Apr 25
Roxanne Khamsi explores genetic mosaics and somatic mutations in BEYOND INHERITANCE
Updated
Updated · erictopol.substack.com · Apr 25

Roxanne Khamsi explores genetic mosaics and somatic mutations in BEYOND INHERITANCE

6 articles · Updated · erictopol.substack.com · Apr 25
  • Khamsi’s book highlights that our 37 trillion cells undergo 330 billion daily turnovers, causing trillions of somatic mutations, and discusses new research linking these mutations to diseases like Alzheimer’s and cancer.
  • Topics include cellular competition, single-cell sequencing advances, immune system diversity, and how environmental factors like UV light and pollution induce mutations. The book also examines adaptive cancer therapies and natural gene therapy through mutation autocorrection.
  • Khamsi’s work underscores the dynamic, ever-changing nature of our genomes, the role of somatic mutations across the lifespan, and their implications for aging, disease risk, and future medical strategies.
Can our bodies perform 'natural gene therapy' to reverse deadly diseases?
Does chemotherapy create new dangers by mutating our healthy tissues?
Is your daily life secretly rewriting your DNA and aging you faster?
If your genetic code changes daily, what does that mean for your identity?
What is the biological secret of 'super agers' who defy brain decline?
Could existing cancer drugs be the key to halting Alzheimer's disease?

The Mosaic Self: How Somatic Mutations Redefine Human Health and Aging

Overview

Roxanne Khamsi's 2025 book, Beyond Inheritance, revolutionized genetics by revealing that humans are genetic mosaics, with trillions of cells acquiring unique mutations throughout life. These somatic mutations, driven by internal processes and environmental exposures like air pollution, contribute not only to cancer but also to aging and diseases such as cardiovascular conditions through clonal expansions like CHIP. Advances in detection technologies raise ethical challenges around screening and privacy, while CRISPR gene editing offers promising but complex therapeutic possibilities. AI platforms and senolytic drugs are accelerating personalized interventions, marking a shift toward proactive, precise medicine that embraces our dynamic, ever-changing genetic identity.

...